Free Monthly Newsletter

The Research Roundup

Practical regulatory tips, industry updates, training insights, and real-world guidance from Nicole Berry, BSPH — Founder & Principal Consultant at The Odom Group, Inc., with 25+ years in clinical research.

All Issues

1 issue published
Issue No.
01
April 2026

The One Thing That Prevents Most Form 483s

After 25 years and hundreds of monitoring visits, I can tell you that the majority of FDA Form 483 observations trace back to one root cause: documentation that does not match reality in real time. In this issue: three habits that close the gap, what sponsors are watching right now, and a deep dive into ICH E6(R3).

Form 483 PreventionDocumentation HabitsICH E6(R3)Risk-Based Monitoring
Coming soon — subscribe to be first
Free Monthly Newsletter

Get The Research Roundup in Your Inbox

Every month: practical regulatory tips, industry updates, training insights, and real-world guidance from 25+ years in clinical research. No spam. Unsubscribe anytime.

Monthly. No spam. Unsubscribe anytime.